We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biosimilars Can't Circumvent BPCIA With Litigation

Law360, New York (December 13, 2013, 2:59 PM EST) -- The United States District Court for the Northern District of California ruled on Nov. 12, 2013, that a party seeking to obtain approval of a biosimilar could not avoid the process...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.